Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus sufentanil for pain reduction after forearm fracture surgery under supraclavicular block
IRCT20191025045235N3Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine, sufentanil, lidocaine and epinephrine in postoperative pain (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Postoperative pain control. Started Apr 2025; status: completed.
02
Drugs
dexmedetomidinesufentanillidocaineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20191025045235N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191025045235N3.